Almac Group ltd.
About Almac Group
‘Partnering to Advance Human Health’
Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services to the pharmaceutical and biotech sectors globally. Solutions range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The privately owned, global organisation has grown organically over 50 years now employing over 5,600 highly skilled personnel and has a strong reputation for innovation, quality and exceptional customer service.
The Group is headquartered in Northern Ireland with 18 operations across Europe, the US (Pennsylvania, North Carolina and California) and Asia (Singapore and Tokyo).
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||API Contract Manufacturing |Bio Services |Biocatalysts More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany We were at stand 121C42 See our Exhibitor Profile See full Exhibitor List
CPhI Korea 201921-23 August 2019 Seoul, Korea We were at stand D11 See our Exhibitor Profile See full Exhibitor List
Our Top products
API Services, Chemical Development & Manufacture
Almac’s strength in API development and manufacture is proven by being the partner of choice for many pharma and biotech companies seeking integrated drug development solutions from molecule to market.
Our technical expertise and extensive facilities enable us to offer integrated API contract manuf...
QC and analytical support, including method development and validation, method transfer and radiolabelling stability studies
With our extensive experience in the synthesis and analysis of stable and 14C isotope labelled compounds – from drug discovery thr...
From our state-of-the-art analytical laboratories in the UK and US, our highly skilled analysts deliver comprehensive solutions to support drug substance (API) and drug product development programs. Analytical and microbiological testing solutions for clinical and commercial drug product supply are also provi...More info
News about Almac Group ltd.
26 Jul 2019
Almac Group expands US specialised commercial packaging capabilities
Audubon, PA, 16 April 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to announce that it has expanded its US commercial packaging capabilities at its Audubon, PA facility.Read more
25 Jul 2019
Almac Group Reports Further Growth During Period of Significant Global Expansion
2017-18 figures record turnover increased by £17 million with 8% growth in global workforce.Read more
25 Jul 2019
Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing
Almac Group, the global contract development and manufacturing organization, is delighted to announce that they have brought online a second stream for High Throughput GMP Peptide manufacturing.Read more
25 Jul 2019
Almac Group Recognized with Six Life Science Leader CMO Awards
Almac Group, the global contract development and manufacturing organization, is delighted to announce it has won awards in all core categories for 2019 for excellence in Quality, Reliability, Capabilities, Expertise, Compatibility, and Service.Read more
Categories affiliated with Almac Group ltd.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation